Answers are grounded in this paper and cite their sources.
To review our experience with >100 patients with primary obstructive megaureter (POM) undergoing endoscopic balloon dilatation (EBD) and a follow-up of up to 12 years and determine potential risk factors for failure. Our hypothesis is that EBD allows for long-term treatment in >80% of patients, and its effectiveness decreases in more severe cases.
No takes yet. Share an insight, caveat, or question.
Mele et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: